The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Furosemide Bristol 40 mg Tablets

Brillpharma (Ireland) LimitedPA22749/001/002

Main Information

Trade NameFurosemide Bristol 40 mg Tablets
Active SubstancesFurosemide
Dosage FormTablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/001/002

Group Information

ATC CodeC03CA Sulfonamides, plain
C03CA01 furosemide


License statusAuthorised
Licence Issued26/05/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back